Details for 2013179231

Up to date per 30.04.2026

Actions

Title / Product Name

Bevacizumab zur Verwendung in der Behandlung von altersbedingter atrophischer Makuladegeneration

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2013179231

EP Publication Number

2664347

E-Number

1106714

Language

PCT Number

Publication Date

20.11.2013 A

13.03.2019 B1

Registration Date

13.03.2019

AT Publication Date

15.03.2019

Application Date

13.07.2009

Registration Number

Priorities

18.07.2008

176238

IPC

A61K 9/00 20060101AFI20181002BHEP

Maximum Duration of Protection

13.07.2029

Owner

ALLERGAN, INC.2525 Dupont Drive Irvine, CA 92612US

Representative

No representatives present

Inventor

Robinson, Michael R.8 Ghiberti Irvine, CA California 92606US

Blanda, Wendy M.158 N. B Street Tustin, CA California 92780US

Hughes, Patrick M.2 Somerset Drive Aliso Viejo, CA California 92656US

Burke, A. James2409 East Avalon Avenue Santa Ana, CA California 92705US

Whitcup, Scott M.27591 Lost Trail Drive Laguna Hill, CA California 92653US